BioSpace News Archive

Business

MannKind and United Therapeutics Ink $95 Million+ Deal

MannKind Corporation, based in Westlake Village, California, and United Therapeutics, located in Silver Spring, Maryland, signed a worldwide exclusive license and collaboration deal to develop and commercialize a dry powder formulation of treprostinil.

September 4, 2018
·
3 min read
·
Mark Terry
Drug Development

Abivax Bolstered by Positive Mid-Stage Results from Ulcerative Colitis Treatment

Shares of Paris-based Abivax have shot up more than 8 percent this morning after the company posted positive mid-stage results for its ulcerative colitis treatment, ABX464.

September 4, 2018
·
2 min read
·
Alex Keown
Ahren Fund to Invest $10 Million in Cambridge Epigenetix

Eight so-called “superstar scientists” based in Cambridge, UK, have co-founded an investment fund dubbed Ahren with 100 million pounds, so far. One of their first investments is in biotech company Cambridge Epigenetix for $10 million.

September 4, 2018
·
2 min read
·
Mark Terry
Business

Tempus Data Analytics Firm Hits $2 Billion Valuation, One of a Handful of Chicago “Unicorns”

On August 29, Chicago-based Tempus, which focuses on data analytics for molecular and clinical data, announced it had raised $110 million in Series E financing. This brought total money raised so far to $320 million. This also gave the company a valuation of $2 billion.

September 4, 2018
·
3 min read
·
Mark Terry
Price Increase in EU Calls Comparisons Between Leadiant Biosciences and Martin Shkreli

More than a year after Maryland-based Sigma-Tau Pharmaceuticals changed its name to Leadiant Biosciences, the newly-dubbed company is now being associated with a much darker name – that of jailed biotech entrepreneur Martin Shkreli.

September 4, 2018
·
2 min read
·
Alex Keown
VIRUSES AGAINST BACTERIA: DEVELOPMENT OF NOVEL THERAPEUTICS BOOSTED WITH MILLIONS OF EUROS

The development of alternative therapies to combat antibiotic-resistant bacteria has attracted more than €4 million in grants and private investments for Vienna-based biotech company PhagoMed Biopharma GmbH (PhagoMed).

September 4, 2018
·
4 min read